Long-lasting HIV prevention shot headed toward approval
Medical Xpress
JUNE 7, 2025
Many people still face stigma or lack insurance coverage, which can limit access. Most current PrEP users have commercial insurance, but Medicaid will be key for expanding access to lower-income communities. In clinical trials, no participants who received the injection acquired HIV.
64 
Let's personalize your content